Interventional Oncology Device Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL INTERVENTIONAL ONCOLOGY DEVICE INDUSTRY

2.1 Summary about Interventional Oncology Device Industry

2.2 Interventional Oncology Device Market Trends

2.2.1 Interventional Oncology Device Production & Consumption Trends

2.2.2 Interventional Oncology Device Demand Structure Trends

2.3 Interventional Oncology Device Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Ablation Devices

4.2.2 Embolization Particles

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Lung Cancer

4.3.2 Kidney Cancer

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Ablation Devices

5.2.2 Embolization Particles

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Lung Cancer

5.3.2 Kidney Cancer

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Ablation Devices

6.2.2 Embolization Particles

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Lung Cancer

6.3.2 Kidney Cancer

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Ablation Devices

7.2.2 Embolization Particles

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Lung Cancer

7.3.2 Kidney Cancer

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Ablation Devices

8.2.2 Embolization Particles

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Lung Cancer

8.3.2 Kidney Cancer

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Ablation Devices

9.2.2 Embolization Particles

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Lung Cancer

9.3.2 Kidney Cancer

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Philips Volcano

10.1.2 Boston Scientific

10.1.3 GE Healthcare

10.1.4 Siemens Healthineers

10.1.5 St. Jude Medical

10.1.6 Hitachi Aloka Medical America

10.1.7 Medtronic

10.1.8 Samsung Medison

10.2 Interventional Oncology Device Sales Date of Major Players (2017-2020e)

10.2.1 Philips Volcano

10.2.2 Boston Scientific

10.2.3 GE Healthcare

10.2.4 Siemens Healthineers

10.2.5 St. Jude Medical

10.2.6 Hitachi Aloka Medical America

10.2.7 Medtronic

10.2.8 Samsung Medison

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Interventional Oncology Device Product Type Overview

2.Table Interventional Oncology Device Product Type Market Share List

3.Table Interventional Oncology Device Product Type of Major Players

4.Table Brief Introduction of Philips Volcano

5.Table Brief Introduction of Boston Scientific

6.Table Brief Introduction of GE Healthcare

7.Table Brief Introduction of Siemens Healthineers

8.Table Brief Introduction of St. Jude Medical

9.Table Brief Introduction of Hitachi Aloka Medical America

10.Table Brief Introduction of Medtronic

11.Table Brief Introduction of Samsung Medison

12.Table Products & Services of Philips Volcano

13.Table Products & Services of Boston Scientific

14.Table Products & Services of GE Healthcare

15.Table Products & Services of Siemens Healthineers

16.Table Products & Services of St. Jude Medical

17.Table Products & Services of Hitachi Aloka Medical America

18.Table Products & Services of Medtronic

19.Table Products & Services of Samsung Medison

20.Table Market Distribution of Major Players

21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

23.Table Global Interventional Oncology Device Market Forecast (Million USD) by Region 2021f-2026f

24.Table Global Interventional Oncology Device Market Forecast (Million USD) Share by Region 2021f-2026f

25.Table Global Interventional Oncology Device Market Forecast (Million USD) by Demand 2021f-2026f

26.Table Global Interventional Oncology Device Market Forecast (Million USD) Share by Demand 2021f-2026f